Upto 90% Savings for 75 Lakh+ Customers through Davaindia

Surat (Gujarat) [India], July 1: Davaindia Generic Pharmacy, the leading private generic pharmacy retail chain, a brand of Zota Healthcare Ltd., has successfully provided up to 90% Savings to 75 lakh+ customers who purchase generic medicines from their stores.

Davaindia’s commitment to offering affordable, high-quality generic medicines has revolutionized the Indian healthcare landscape, making essential medications via a range of 2200+ generic medicines accessible to the masses.

Davaindia has become synonymous as cost-effective healthcare solutions, providing customers with not only a comparative cost benefit but also a vast repertoire of medicines & OTC products. Since its inception in 2017, Davaindia has rapidly expanded its presence, establishing more than 600+ retail outlets across the country and serving a vast customer base of over 75 lakh individuals. Davaindia also has given wings to entrepreneurship dreams of 500+ ambitious individuals via it’s robust franchisee network.

The savings offered by Davaindia reflect the company’s dedication to ensuring affordable healthcare to the last mile of the country. By promoting the use of generic medicines, which are the equivalent to their branded counterparts but also available at significantly lower prices, Davaindia has empowered customers to make informed choices that benefit their health and finances.

Zota Healthcare Ltd., the parent company of Davaindia, is renowned for its diverse range of pharmaceutical, nutraceutical, and ayurvedic products. Established in 2000, Zota Healthcare has emerged as a distinguished pharma company, listed on the NSE (National Stock Exchange). The company’s commitment to innovation, quality, and integrity has propelled its growth, allowing it to serve both regulated and semi-regulated markets in Asia, Africa, Russia, and Latin America.

Commenting on this Dr. Sujit Paul the Group CEO – Zota Healthcare Ltd.said, “The success of Davaindia and Zota Healthcare can be attributed to their unwavering focus on providing affordable healthcare solutions without compromising on quality. By prioritizing customer welfare and ensuring accessibility to essential medicines, the companies have positively impacted the lives of millions of individuals across India.”

Davaindia is committed to its aim of making affordable healthcare a reality for every Indian as well as individuals across the globe as it continues to develop its network of retail shops and reach a broader audience. Both Zota Healthcare Ltd. and Davaindia Generic Pharmacy, by their dedication to quality, are changing the face of the pharmaceutical industry and offering new hope to patients in search of low-cost, effective treatments under a single roof.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business

Rikhav Securities Closes FY25 with INR 24 Cr Consolidated Net Profit

New Delhi [India], May 15: Rikhav Securities Limited, (BSE – RIKHAV | 544340), one of the leading diversified stock market services providers has announced its Audited Financial Results for H2 FY25 & FY25. Key Consolidated Financial Highlights FY25 • Total Income of ₹ 327.77 Cr • EBITDA of ₹ 34.50 Cr • EBITDA Margin of 10.53% • Net Profit of ₹ 23.67 Cr • Net Profit Margin of 7.22%% • EPS of ₹ 7.51 Commenting on the financial performance, Mr. Hitesh Lakhani, Chairman & Managing Director, Rikhav Securities Limited said, “This financial year […]

Read More
Business

Arkade Developers Consolidated Q4 FY25 Net Profit Grew By 70%

Mumbai (Maharashtra) [India], May 15: Arkade Developers Limited, (BSE – 544261, NSE – ARKADE) one of the leading real estate development companies focused on developing high-end, sophisticated lifestyle residential developments in Mumbai, Maharashtra, has announced its Audited Financial Results for Q4 FY25 & FY25. Consolidated Key Financial Highlights: Q4 FY25 * Total Income of ₹ […]

Read More
Business

Manaksia Coated Metals & Industries Reports ₹790 Cr Total Income & ₹15 Cr Net Profit in FY25

Mumbai (Maharashtra) [India], May 15: Manaksia Coated Metals & Industries Limited (NSE: MANAKCOAT, BSE: 539046), is one of the leadingcoated metal products manufacturer and exporter. Specializing in Pre-painted Galvanised Steel and Plain Galvanised Steel in both coil and sheet forms, has reported its Audited financials for Q4 FY25 & FY25. Q4 FY25 Consolidated Financial Highlights • […]

Read More